Why the study?
Voice has been suggested as a noninvasive biomarker to monitor disease progression and prevent decompensation in patients with heart failure.
Do speech and pause alterations (pause ratio) differentiate patients with acute heart failure from those with stable heart failure?
Do speech and pause alterations (pause ratio) differentiate patients with acute heart failure from those with stable heart failure?
Pause ratio extracted from voice recordings is increased in acute heart failure compared to stable heart failure and correlates with NT-proBNP, suggesting its potential as a noninvasive vocal biomarker for monitoring decompensation.
Answers are grounded in this paper and cite their sources.
Pause ratio may support noninvasive HF monitoring; leaves open prospective validation for decompensation prediction.
Background Acute heart failure is the most frequent cause of unplanned hospital admission in elderly patients. Various biomarkers have been evaluated to better assess the status of these patients and prevent decompensation. Recently, voice has been suggested as a cost-effective and noninvasive way to monitor disease progression. This study evaluates speech and pause alterations in patients with acute decompensated and stable heart failure. Specifically, we aim to identify a vocal biomarker that could be used to monitor patients with heart failure and to prevent decompensation. Methods and Results Speech and pause patterns were evaluated in 68 patients with acute and 36 patients with stable heart failure. Voice recordings were performed using a web-browser based application that consisted of 5 tasks. Speech and pause patterns were automatically extracted and compared between acute and stable patients and with clinical markers. Compared with stable patients, pause ratio was up to 14.9% increased in patients with acute heart failure. This increase was largely independent of sex, age, and ejection fraction and persisted in patients with lower degrees of edema or dyspnea. Furthermore, pause ratio was positively correlated with NT-proBNP (N-terminal pro-B-type natriuretic peptide) after controlling for acute versus stable heart failure. Collectively, our findings indicate that the pause ratio could be useful in identifying acute heart failure, particularly in patients who do not display traditional indicators of decompensation. Conclusions Speech and pause patterns are altered in patients with acute heart failure. Particularly, we identified pause ratio as an easily interpretable vocal biomarker to support the monitoring of heart failure decompensation.
No takes yet. Share an insight, caveat, or question.
Schöbi et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: